Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Stanford, California
  • +182 more
Jul 1, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Axitinib Therapy Management Study

Withdrawn
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer Inc.
Mar 25, 2022

Kidney Cancer, Renal Cell Carcinoma Trial in New Brunswick, New York, Cleveland (Cabozantinib, Nivolumab, Cytoreductive

Recruiting
  • Kidney Cancer
  • Renal Cell Carcinoma
  • New Brunswick, New Jersey
  • +2 more
Mar 22, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • everolimus and bevacizumab
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2022

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
Has Results
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Renal Cell Carcinoma Trial in United States (Nivolumab, Axitinib)

Recruiting
  • Renal Cell Carcinoma
  • Baltimore, Maryland
  • +3 more
Nov 16, 2021

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • New Haven, Connecticut
  • +5 more
Jul 13, 2021

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)

Completed
Has Results
  • Renal Cell Carcinoma
  • Cabozantinib tablets
  • Everolimus (Afinitor) tablets
  • Birmingham, Alabama
  • +204 more
Apr 1, 2021

Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville

Completed
Has Results
  • Advanced Cancer
  • +5 more
  • Boston, Massachusetts
  • +3 more
Nov 24, 2020

Clinical and Histopathologic Characteristics of BAP1 Mutations

Completed
  • Malignant Pleural Mesothelioma (MPM)
  • +5 more
  • tumor specimens
  • Harrison, New York
  • +1 more
Jun 30, 2020

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
  • +2 more
  • Scottsdale, Arizona
  • +44 more
Dec 19, 2019

Kidney Cancer, Renal Cell Carcinoma Trial in United States (Ceevra Reveal)

Completed
  • Kidney Cancer
  • Renal Cell Carcinoma
  • Ceevra Reveal
  • New York, New York
  • +1 more
Jun 4, 2019

Renal Cell Carcinoma, Melanoma, Lung Cancer Trial in United States (Infliximab + Prednisone, Methylprednisolone + Prednisone)

Withdrawn
  • Renal Cell Carcinoma
  • +2 more
  • Infliximab + Prednisone
  • Methylprednisolone + Prednisone
  • Los Angeles, California
  • +9 more
Oct 5, 2018

Renal Cell Carcinoma, Kidney Cancer Trial in United States (124-Iodine-cG250 (124I-cG250), CT)

Completed
Has Results
  • Renal Cell Carcinoma
  • Kidney Cancer
  • 124-Iodine-cG250 (124I-cG250)
  • CT
  • Los Angeles, California
  • +13 more
Sep 3, 2018

Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

Terminated
  • Advanced Renal Cell Carcinoma
  • +2 more
  • Standard Treatment
  • AGS-003
  • Scottsdale, Arizona
  • +124 more
Jun 13, 2018

Renal Cell Carcinoma, Kidney Cancer Trial in United States (Iodine (124I) Girentuximab)

Withdrawn
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Iodine (124I) Girentuximab
  • Los Angeles, California
  • +7 more
Dec 20, 2017

Primary Tumor, Renal Cell Carcinoma Trial in New York (Stereotactic Body Radiotherapy (SBRT))

Terminated
  • Primary Tumor
  • Renal Cell Carcinoma
  • Stereotactic Body Radiotherapy (SBRT)
  • New York, New York
  • +1 more
Jan 6, 2017

Renal Cell Carcinoma Trial in Worldwide (Everolimus, GDC-0980)

Completed
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +21 more
Aug 8, 2016